JP2024538322A - 乳化剤および薬物キャリアとして使用されるアルブミンタンパク質 - Google Patents

乳化剤および薬物キャリアとして使用されるアルブミンタンパク質 Download PDF

Info

Publication number
JP2024538322A
JP2024538322A JP2024525964A JP2024525964A JP2024538322A JP 2024538322 A JP2024538322 A JP 2024538322A JP 2024525964 A JP2024525964 A JP 2024525964A JP 2024525964 A JP2024525964 A JP 2024525964A JP 2024538322 A JP2024538322 A JP 2024538322A
Authority
JP
Japan
Prior art keywords
albumin
protein
protein fraction
drug
emulsion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024525964A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024538322A5 (cg-RX-API-DMAC7.html
Inventor
ジャフィー,アーサー
シュルツ,ダン
Original Assignee
イーシーエス ブランズ,リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by イーシーエス ブランズ,リミテッド filed Critical イーシーエス ブランズ,リミテッド
Publication of JP2024538322A publication Critical patent/JP2024538322A/ja
Publication of JP2024538322A5 publication Critical patent/JP2024538322A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5052—Proteins, e.g. albumin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/10—Foods or foodstuffs containing additives; Preparation or treatment thereof containing emulsifiers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5169—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Physiology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Botany (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
JP2024525964A 2021-10-26 2022-10-26 乳化剤および薬物キャリアとして使用されるアルブミンタンパク質 Pending JP2024538322A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163272088P 2021-10-26 2021-10-26
US63/272,088 2021-10-26
PCT/US2022/047934 WO2023076425A1 (en) 2021-10-26 2022-10-26 Albumin protein for use as an emulsifier and drug carrier

Publications (2)

Publication Number Publication Date
JP2024538322A true JP2024538322A (ja) 2024-10-18
JP2024538322A5 JP2024538322A5 (cg-RX-API-DMAC7.html) 2025-11-06

Family

ID=86158481

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024525964A Pending JP2024538322A (ja) 2021-10-26 2022-10-26 乳化剤および薬物キャリアとして使用されるアルブミンタンパク質

Country Status (8)

Country Link
US (1) US20250009673A1 (cg-RX-API-DMAC7.html)
EP (1) EP4422600A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024538322A (cg-RX-API-DMAC7.html)
CN (1) CN118574604A (cg-RX-API-DMAC7.html)
AU (1) AU2022376283A1 (cg-RX-API-DMAC7.html)
CA (1) CA3236501A1 (cg-RX-API-DMAC7.html)
MX (1) MX2024005206A (cg-RX-API-DMAC7.html)
WO (1) WO2023076425A1 (cg-RX-API-DMAC7.html)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7771751B2 (en) * 2005-08-31 2010-08-10 Abraxis Bioscience, Llc Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial agents
WO2013067603A1 (en) * 2011-11-10 2013-05-16 Clover Corporation Limited Encapsulation of food ingredients supplements and pharmaceuticals
CN104302193A (zh) * 2012-03-16 2015-01-21 詹尼弗·赖特 基于大麻的婴儿配方食品和制备其的方法
WO2019213757A1 (en) * 2018-05-07 2019-11-14 POS Management Corp. Hemp protein and use for microencapsulation
WO2020186246A1 (en) * 2019-03-13 2020-09-17 Ulagaraj Selvaraj Stabilized solid nanoparticle formulations of cannabinoids and cannabinoid analogs with reduced ostwald ripening for oral, inhalation, nasal and parenteral drug delivery
PH12022550262A1 (en) * 2019-09-23 2022-11-21 Unilever Ip Holdings B V Oil-in-water emulsion comprising plant protein
EP4084790A1 (en) * 2020-01-02 2022-11-09 Yissum Research Development Company of The Hebrew University of Jerusalem Ltd. Floating drug delivery systems comprising cannabinoids

Also Published As

Publication number Publication date
AU2022376283A1 (en) 2024-06-13
EP4422600A4 (en) 2025-12-10
WO2023076425A1 (en) 2023-05-04
CN118574604A (zh) 2024-08-30
US20250009673A1 (en) 2025-01-09
EP4422600A1 (en) 2024-09-04
CA3236501A1 (en) 2023-05-04
MX2024005206A (es) 2024-09-23

Similar Documents

Publication Publication Date Title
Jafari et al. Nanotechnology-abetted astaxanthin formulations in multimodel therapeutic and biomedical applications
Pérez-Pérez et al. Exploring the impact of encapsulation on the stability and bioactivity of peptides extracted from botanical sources: Trends and opportunities
Chaves et al. Current applications of liposomes for the delivery of vitamins: a systematic review
Light et al. Emulsion, hydrogel and emulgel systems and novel applications in cannabinoid delivery: A review
Wei et al. Assembly of protein–polysaccharide complexes for delivery of bioactive ingredients: A perspective paper
Zhang et al. Protein-based high internal phase pickering emulsions: A review of their fabrication, composition and future perspectives in the food industry
McClements Nanoparticle-and microparticle-based delivery systems: Encapsulation, protection and release of active compounds
Teng et al. Beta-lactoglobulin-based encapsulating systems as emerging bioavailability enhancers for nutraceuticals: a review
Sun et al. Recent research advances in astaxanthin delivery systems: Fabrication technologies, comparisons and applications
JP5016111B2 (ja) 植物精油を含有するナノエマルジョンおよびナノ粒子ならびにそれらの製造方法
Chen et al. Recent progress in fish oil-based emulsions by various food-grade stabilizers: Fabrication strategy, interfacial stability mechanism and potential application
KR20120124745A (ko) 포스파티딜세린의 마이크로캡슐화 방법
Gao et al. Advances in encapsulation systems of Antarctic krill oil: From extraction to encapsulation, and future direction
KR101659654B1 (ko) 불포화지방산 및 시나몬 오일이 포집된 다중층 나노 캡슐의 제조방법
Cai et al. Encapsulated microstructures of beneficial functional lipids and their applications in foods and biomedicines
Yuan et al. Efficient utilization of tea resources through encapsulation: dual perspectives from core material to wall material
Ozsoysal et al. Non-traditional natural stabilizers in drug nanosuspensions
Wang et al. On-chip precisely controlled preparation of uniform core–shell salmon byproduct protein/polysaccharide microcapsules for enhancing probiotic survivability in fruit juice
CN110101084B (zh) 由蛋黄蛋白肽颗粒稳定的海藻油纳米皮克林乳液与油粉及其制备方法与应用
Wang et al. Oral barriers to food‐derived active peptides and nano‐delivery strategies
CN102302450A (zh) 疏水药物-白蛋白-葡聚糖纳米乳液及其制备方法和应用
Noore et al. Nanocarriers for controlled release and target delivery of bioactive compounds
CN116376068B (zh) 一种植酸交联淀粉-蛋白质复合物协同稳定的双重乳液及在医药领域的应用
US20250009673A1 (en) Albumin protein for use as an emulsifier and drug carrier
Alam et al. Octenylsuccinylated starch and pea protein-stabilized emulsions enhance lutein stability and bioavailability

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251027

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20251027